| SC 13D/A | 2024-04-10 | TAKEDA PHARMACEUTICAL CO LTD | Phathom Pharmaceuticals, Inc. | 2,790,480 | 4.8% | EDGAR |
| SC 13D/A | 2024-04-01 | TAKEDA PHARMACEUTICAL CO LTD | Phathom Pharmaceuticals, Inc. | 3,153,217 | 5.4% | EDGAR |
| SC 13G/A | 2024-02-06 | BlackRock Inc. | TAKEDA PHARMACEUTICAL CO LTD | 121,185,145 | 7.7% | EDGAR |
| SC 13G/A | 2024-02-05 | Sumitomo Mitsui Trust Holdings, Inc. | TAKEDA PHARMACEUTICAL CO LTD | 87,400,834 | 5.5% | EDGAR |
| SC 13D/A | 2024-01-25 | TAKEDA PHARMACEUTICAL CO LTD | Phathom Pharmaceuticals, Inc. | 3,755,583 | 6.6% | EDGAR |
| SC 13G | 2024-01-19 | TAKEDA PHARMACEUTICAL CO LTD | Equillium, Inc. | 1,842,977 | 5.2% | EDGAR |
| SC 13D/A | 2023-05-26 | TAKEDA PHARMACEUTICAL CO LTD | Calithera Biosciences, Inc. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2023-02-07 | BlackRock Inc. | TAKEDA PHARMACEUTICAL CO LTD | 113,749,385 | 7.2% | EDGAR |
| SC 13G/A | 2023-02-03 | Sumitomo Mitsui Trust Holdings, Inc. | TAKEDA PHARMACEUTICAL CO LTD | 93,599,534 | 5.9% | EDGAR |
| SC 13G/A | 2023-02-03 | TAKEDA PHARMACEUTICAL CO LTD | Ovid Therapeutics Inc. | 8,781,996 | 12.2% | EDGAR |
| SC 13G/A | 2023-02-03 | TAKEDA PHARMACEUTICAL CO LTD | Day One Biopharmaceuticals, Inc. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2022-08-05 | TAKEDA PHARMACEUTICAL CO LTD | BiomX Inc. | 1,478,286 | 5.0% | EDGAR |
| SC 13D/A | 2022-07-06 | TAKEDA PHARMACEUTICAL CO LTD | Calithera Biosciences, Inc. | 857,844 | 15.0% | EDGAR |
| SC 13D | 2022-05-09 | TAKEDA PHARMACEUTICAL CO LTD | HilleVax, Inc. | 6,724,000 | 17.1% | EDGAR |
| SC 13D | 2022-04-21 | TAKEDA PHARMACEUTICAL CO LTD | Calithera Biosciences, Inc. | 14,817,484 | 13.2% | EDGAR |
| SC 13G/A | 2022-02-04 | Sumitomo Mitsui Trust Holdings, Inc. | TAKEDA PHARMACEUTICAL CO LTD | 90,913,734 | 5.7% | EDGAR |
| SC 13G/A | 2022-02-03 | BlackRock Inc. | TAKEDA PHARMACEUTICAL CO LTD | 104,941,952 | 6.6% | EDGAR |
| SC 13G/A | 2022-01-14 | TAKEDA PHARMACEUTICAL CO LTD | Shattuck Labs, Inc. | 2,090,858 | 5.0% | EDGAR |
| SC 13G | 2022-01-14 | TAKEDA PHARMACEUTICAL CO LTD | Day One Biopharmaceuticals, Inc. | 6,012,758 | 9.7% | EDGAR |
| SC 13G | 2022-01-14 | TAKEDA PHARMACEUTICAL CO LTD | Xilio Therapeutics, Inc. | 1,475,121 | 5.4% | EDGAR |